KNSA logo

Kiniksa Pharmaceuticals (KNSA) Free cash flow

annual FCF:

$25.41M+$12.24M(+92.94%)
December 31, 2024

Summary

  • As of today (May 29, 2025), KNSA annual free cash flow is $25.41 million, with the most recent change of +$12.24 million (+92.94%) on December 31, 2024.
  • During the last 3 years, KNSA annual FCF has risen by +$172.13 million (+117.32%).
  • KNSA annual FCF is now at all-time high.

Performance

KNSA Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAcash flow metrics

quarterly FCF:

$22.23M+$3.65M(+19.64%)
March 31, 2025

Summary

  • As of today (May 29, 2025), KNSA quarterly free cash flow is $22.23 million, with the most recent change of +$3.65 million (+19.64%) on March 31, 2025.
  • Over the past year, KNSA quarterly FCF has increased by +$18.32 million (+469.43%).
  • KNSA quarterly FCF is now -64.17% below its all-time high of $62.03 million, reached on September 30, 2022.

Performance

KNSA quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAcash flow metrics

TTM FCF:

$43.73M+$18.32M(+72.10%)
March 31, 2025

Summary

  • As of today (May 29, 2025), KNSA TTM free cash flow is $43.73 million, with the most recent change of +$18.32 million (+72.10%) on March 31, 2025.
  • Over the past year, KNSA TTM FCF has increased by +$22.37 million (+104.70%).
  • KNSA TTM FCF is now at all-time high.

Performance

KNSA TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

KNSA Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+92.9%+469.4%+104.7%
3 y3 years+117.3%+160.3%+135.4%
5 y5 years+115.7%+169.4%+134.0%

KNSA Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+117.3%-64.2%+160.3%at high+135.4%
5 y5-yearat high+115.7%-64.2%+136.9%at high+125.0%
alltimeall timeat high+115.7%-64.2%+134.3%at high+125.0%

KNSA Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
$22.23M(+19.6%)
$43.73M(+72.1%)
Dec 2024
$25.41M(+92.9%)
$18.58M(-930.8%)
$25.41M(+128.9%)
Sep 2024
-
-$2.24M(-143.3%)
$11.10M(-63.4%)
Jun 2024
-
$5.17M(+32.4%)
$30.31M(+41.9%)
Mar 2024
-
$3.90M(-8.6%)
$21.36M(+62.2%)
Dec 2023
$13.17M(+131.0%)
$4.27M(-74.8%)
$13.17M(-598.5%)
Sep 2023
-
$16.97M(-549.3%)
-$2.64M(-106.2%)
Jun 2023
-
-$3.78M(-12.0%)
$42.42M(+10.9%)
Mar 2023
-
-$4.29M(-62.8%)
$38.26M(+570.9%)
Dec 2022
$5.70M(-103.9%)
-$11.54M(-118.6%)
$5.70M(-401.9%)
Sep 2022
-
$62.03M(-881.3%)
-$1.89M(-98.0%)
Jun 2022
-
-$7.94M(-78.5%)
-$92.48M(-25.0%)
Mar 2022
-
-$36.85M(+92.6%)
-$123.38M(-15.9%)
Dec 2021
-$146.71M(+7.2%)
-$19.14M(-33.0%)
-$146.71M(-13.1%)
Sep 2021
-
-$28.56M(-26.5%)
-$168.82M(-3.3%)
Jun 2021
-
-$38.84M(-35.5%)
-$174.59M(+5.8%)
Mar 2021
-
-$60.18M(+45.9%)
-$164.97M(+20.6%)
DateAnnualQuarterlyTTM
Dec 2020
-$136.81M(-15.3%)
-$41.25M(+20.2%)
-$136.81M(+12.4%)
Sep 2020
-
-$34.33M(+17.5%)
-$121.73M(+3.9%)
Jun 2020
-
-$29.22M(-8.7%)
-$117.12M(-9.1%)
Mar 2020
-
-$32.02M(+22.4%)
-$128.77M(-20.3%)
Dec 2019
-$161.57M(+87.2%)
-$26.17M(-11.9%)
-$161.57M(-3.3%)
Sep 2019
-
-$29.71M(-27.3%)
-$167.06M(+5.2%)
Jun 2019
-
-$40.88M(-36.9%)
-$158.80M(+16.7%)
Mar 2019
-
-$64.82M(+104.8%)
-$136.07M(+57.7%)
Dec 2018
-$86.30M(+71.6%)
-$31.65M(+47.6%)
-$86.30M(+10.6%)
Sep 2018
-
-$21.45M(+18.2%)
-$78.03M(+15.5%)
Jun 2018
-
-$18.15M(+20.6%)
-$67.55M(+13.3%)
Mar 2018
-
-$15.05M(-35.6%)
-$59.64M(+18.6%)
Dec 2017
-$50.29M(+129.9%)
-$23.38M(+113.1%)
-$50.29M(+86.9%)
Sep 2017
-
-$10.97M(+7.2%)
-$26.91M(+68.9%)
Jun 2017
-
-$10.24M(+79.7%)
-$15.93M(+179.7%)
Mar 2017
-
-$5.70M
-$5.70M
Dec 2016
-$21.87M
-
-

FAQ

  • What is Kiniksa Pharmaceuticals annual free cash flow?
  • What is the all time high annual FCF for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals annual FCF year-on-year change?
  • What is Kiniksa Pharmaceuticals quarterly free cash flow?
  • What is the all time high quarterly FCF for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals quarterly FCF year-on-year change?
  • What is Kiniksa Pharmaceuticals TTM free cash flow?
  • What is the all time high TTM FCF for Kiniksa Pharmaceuticals?
  • What is Kiniksa Pharmaceuticals TTM FCF year-on-year change?

What is Kiniksa Pharmaceuticals annual free cash flow?

The current annual FCF of KNSA is $25.41M

What is the all time high annual FCF for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high annual free cash flow is $25.41M

What is Kiniksa Pharmaceuticals annual FCF year-on-year change?

Over the past year, KNSA annual free cash flow has changed by +$12.24M (+92.94%)

What is Kiniksa Pharmaceuticals quarterly free cash flow?

The current quarterly FCF of KNSA is $22.23M

What is the all time high quarterly FCF for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high quarterly free cash flow is $62.03M

What is Kiniksa Pharmaceuticals quarterly FCF year-on-year change?

Over the past year, KNSA quarterly free cash flow has changed by +$18.32M (+469.43%)

What is Kiniksa Pharmaceuticals TTM free cash flow?

The current TTM FCF of KNSA is $43.73M

What is the all time high TTM FCF for Kiniksa Pharmaceuticals?

Kiniksa Pharmaceuticals all-time high TTM free cash flow is $43.73M

What is Kiniksa Pharmaceuticals TTM FCF year-on-year change?

Over the past year, KNSA TTM free cash flow has changed by +$22.37M (+104.70%)
On this page